Biosimilars Market 2018 With Key Players Like Amgen, Inc, AstraZeneca, Pfizer, Inc., BIOCON Limited, Novartis AG, STADA, Teva Pharmaceuticals Inc. and Others
Biosimilars Market, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years.
(EMAILWIRE.COM, April 12, 2018 ) Global Biosimilars Market – Industry Analysis, Share, Trend, Market Size and Forecast was estimated to be around US$ 6.45 billion in 2017 and is anticipated to grow with 55.0% of growth rate during the future period. This report segments the global Biosimilars Market by product type, application and geography. Biosimilars are the biologics pharmaceutical drugs which are similar to the reference biologic products. These drugs are an interchangeable biological product that contains synthetically developed protein molecules. When the patent of branded drug is expired, pharmaceutical companies are planning to develop off-patent biologics i.e. biosimilars that offer similar biological activity. The biosimilars market offers many growth opportunities and driving factors as compared to the restraining factors. It is stated by various research scientists that development of biosimilars will drastically reduce the price of pharmaceutical drugs.
In terms of product types, the market for recombinant glycosylated proteins continue to dominate during the forecast period, while the market for recombinant non-glycosylated proteins biosimilars will see a huge potential during the forecast period. On other side, oncology was the largest application segment in 2016, and expected to be the fastest growing application segment in the forecast period. The rise in the aging population, increasing cancer patients, and rise of hospital acquired infection patients globally are factors responsible for the growth of this application segment. The market size and forecast for each segment has been provided for the period 2014 to 2025, considering 2016 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2017 to 2025 for every reported segment.
FREE | Request Sample Copy is Available at http://www.reportsweb.com/inquiry&RW00011327804/sample
The report aims at estimating the market size and future growth potential of market across different segments, such as product types, application and regions. The years considered for the study are:
Historical Year – 2014 & 2015
Base Year – 2016
Estimated Year – 2017
Projected Year – 2025
Companies reported in this report are:
Amgen, Inc, AstraZeneca, Pfizer, Inc., BIOCON Limited, Novartis AG, STADA, Teva Pharmaceuticals Inc. and Others.
For company profiles in the report, 2014 has been considered. Where information is unavailable for the base year, the prior year has been considered.
Check for Discount at http://www.reportsweb.com/inquiry&RW00011327804/discount
TARGET AUDIENCE
Hospitals
Manufacturers
Traders, Distributors, And Suppliers of Biosimilars
Government and Regional Agencies and Research Organizations
Consultants
Distributors
SCOPE OF THE REPORT
The research report categorizes the Biosimilars Market in each of the following submarkets to forecast the revenues and analyze the trends:
GLOBAL BIOSIMILARS MARKET, BY PRODUCT TYPES
Recombinant Glycosylated Proteins
Recombinant Non-Glycosylated Proteins
Recombinant Peptides
GLOBAL BIOSIMILARS MARKET, BY APPLICATION
Oncology
Blood Disorders
Infectious Diseases
Autoimmune Diseases
Others
Inquire before Buying at http://www.reportsweb.com/inquiry&RW00011327804/buying
About ReportsWeb:
ReportsWeb is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers.
Contact Us:
Phone: +1-646-491-9876
Email Id: sales@reportsweb.com
In terms of product types, the market for recombinant glycosylated proteins continue to dominate during the forecast period, while the market for recombinant non-glycosylated proteins biosimilars will see a huge potential during the forecast period. On other side, oncology was the largest application segment in 2016, and expected to be the fastest growing application segment in the forecast period. The rise in the aging population, increasing cancer patients, and rise of hospital acquired infection patients globally are factors responsible for the growth of this application segment. The market size and forecast for each segment has been provided for the period 2014 to 2025, considering 2016 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2017 to 2025 for every reported segment.
FREE | Request Sample Copy is Available at http://www.reportsweb.com/inquiry&RW00011327804/sample
The report aims at estimating the market size and future growth potential of market across different segments, such as product types, application and regions. The years considered for the study are:
Historical Year – 2014 & 2015
Base Year – 2016
Estimated Year – 2017
Projected Year – 2025
Companies reported in this report are:
Amgen, Inc, AstraZeneca, Pfizer, Inc., BIOCON Limited, Novartis AG, STADA, Teva Pharmaceuticals Inc. and Others.
For company profiles in the report, 2014 has been considered. Where information is unavailable for the base year, the prior year has been considered.
Check for Discount at http://www.reportsweb.com/inquiry&RW00011327804/discount
TARGET AUDIENCE
Hospitals
Manufacturers
Traders, Distributors, And Suppliers of Biosimilars
Government and Regional Agencies and Research Organizations
Consultants
Distributors
SCOPE OF THE REPORT
The research report categorizes the Biosimilars Market in each of the following submarkets to forecast the revenues and analyze the trends:
GLOBAL BIOSIMILARS MARKET, BY PRODUCT TYPES
Recombinant Glycosylated Proteins
Recombinant Non-Glycosylated Proteins
Recombinant Peptides
GLOBAL BIOSIMILARS MARKET, BY APPLICATION
Oncology
Blood Disorders
Infectious Diseases
Autoimmune Diseases
Others
Inquire before Buying at http://www.reportsweb.com/inquiry&RW00011327804/buying
About ReportsWeb:
ReportsWeb is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers.
Contact Us:
Phone: +1-646-491-9876
Email Id: sales@reportsweb.com
Contact Information:
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results